Who owns AVBP?
Institutional ownership of ArriVent BioPharma Inc. from Form 13F, Q2 2026
158 institutional managers reported holding ArriVent BioPharma Inc. (AVBP) in Form 13F filings for Q2 2026, with 46,122,681 shares worth $1.6B. The largest reported holder was Montanova Capital, LLC. Managers that filed both quarters added a net 4,022,481 shares (+9.6%). 34 opened new positions and 15 sold out.
- Funds holding
- 158
- Value held
- $1.6B
- New / sold out
- 34 / 15
- Net shares, same filers
- +9.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AVBP
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Montanova Capital, LLC | $157M | 9.8% | 4,515,531 | Added |
| Infinitum Asset Management, LLC | $154M | 9.6% | 4,438,384 | Added |
| HHLR Advisors, LTD. | $136M | 8.5% | 3,929,117 | Unchanged |
| BlackRock, Inc. | $113M | 7.0% | 3,250,396 | Added |
| Orbimed Advisors LLC | $105M | 6.6% | 3,027,328 | Unchanged |
| FMR LLC | $96.5M | 6.0% | 2,778,959 | Trimmed |
| Octagon Capital Advisors LP | $68.5M | 4.3% | 1,971,054 | Unchanged |
| Vanguard Capital Management LLC | $61.7M | 3.8% | 1,774,873 | Added |
| Sofinnova Investments, Inc. | $58.9M | 3.7% | 1,696,752 | Unchanged |
| State Street Corp | $58.8M | 3.7% | 1,692,986 | Added |
| Vivo Capital, LLC | $58.4M | 3.6% | 1,682,097 | Added |
| Novo Holdings A/S | $52.1M | 3.3% | 1,500,000 | Trimmed |
| General Catalyst Group Management, LLC | $51.9M | 3.2% | 1,494,786 | Unchanged |
| Logos Global Management LP | $34.7M | 2.2% | 1,000,000 | Added |
| Geode Capital Management, LLC | $33.8M | 2.1% | 972,626 | Added |
| D. E. Shaw & Co., Inc. | $30.3M | 1.9% | 872,011 | Added |
| Goldman Sachs Group Inc | $29.7M | 1.9% | 853,723 | Unchanged |
| HSG Holding Ltd | $23.0M | 1.4% | 663,308 | Unchanged |
| Point72 Asset Management, L.P. | $19.7M | 1.2% | 566,796 | Trimmed |
| Millennium Management LLC | $15.2M | 1.0% | 438,664 | Added |
| UBS Group AG | $15.2M | 1.0% | 438,594 | Trimmed |
| Balyasny Asset Management L.P. | $13.7M | 0.9% | 395,447 | Trimmed |
| Ameriprise Financial Inc | $13.3M | 0.8% | 381,589 | Added |
| Vanguard Portfolio Management LLC | $11.6M | 0.7% | 335,320 | Added |
| Northern Trust Corp | $11.6M | 0.7% | 332,753 | Added |
Share of 13F holdings is each fund's shares as a share of the 46,122,681 AVBP shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Vivo Capital, LLC Added+$27.7M
- BlackRock, Inc. Added+$25.0M
- Logos Global Management LP Added+$22.6M
- D. E. Shaw & Co., Inc. Added+$17.5M
- Foresite Capital Management VI LLC New+$10.5M
- Infinitum Asset Management, LLC Added+$10.1M
- State Street Corp Added+$9.4M
- Vanguard Capital Management LLC Added+$8.5M
- Acuta Capital Partners, LLC New+$7.6M
- Ameriprise Financial Inc Added+$7.0M
Biggest sellers in Q2 2026
- Novo Holdings A/S Trimmed-$15.4M
- Fund 1 Investments, LLC Sold out-$11.5M
- FMR LLC Trimmed-$8.2M
- Point72 Asset Management, L.P. Trimmed-$6.3M
- ADAR1 Capital Management, LLC Sold out-$3.3M
- Nomura Holdings Inc Trimmed-$3.0M
- Polymer Capital Management (HK) LTD Sold out-$2.8M
- Affinity Asset Advisors, LLC Trimmed-$1.7M
- UBS Group AG Trimmed-$1.7M
- Qube Research & Technologies Ltd Sold out-$1.6M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $216M and sold $64.8M; 70 added and 30 trimmed.
Schedule 13D and 13G filings on AVBP
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-01-21BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-10-30VANGUARD GROUP INC SCHEDULE 13G filed by ArriVent BioPharma Inc.Schedule 13G
- 2025-10-15HBM Healthcare Investments (Cayman) Ltd. SCHEDULE 13G filed by ArriVent BioPharma Inc.Schedule 13G
- 2025-02-15Novo Holdings A/S SCHEDULE 13G filed by ArriVent BioPharma Inc.Schedule 13G
Questions about AVBP ownership
- Who owns AVBP stock?
- 158 institutional investment managers reported AVBP positions in their Form 13F filings for Q2 2026, holding 46,122,681 shares worth $1.6B in total. Montanova Capital, LLC reported the largest position.
- Are funds buying or selling AVBP?
- In Q2 2026, 34 managers opened new AVBP positions, 70 added, 30 trimmed and 15 sold out. Managers that filed in both quarters added a net 4,022,481 shares.
- How current is this AVBP institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AVBP by CUSIP. Options are left out. AVBP news and filings · AVBP insider trades · Top funds